Steven Cohen's Firm Increases Stake in Abeona Therapeutics Inc [Yahoo! Finance]
Abeona Therapeutics Inc. (ABEO)
Last abeona therapeutics inc. earnings: 3/16 04:20 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.abeonatherapeutics.com
Company Research
Source: Yahoo! Finance
Therapeutics Inc ( NASDAQ:ABEO ). The transaction, which took place on December 31, 2023, saw the firm add 468,670 shares to its holdings in the biopharmaceutical company. This move reflects Cohen's strategic investment decisions and his firm's confidence in the future of Abeona Therapeutics. Steven Cohen Trades Portfolio ) and Point72 Asset Management Warning! GuruFocus has detected 5 Warning Signs with ABEO. Steven A. Cohen, the Chairman and CEO of Point72 Asset Management, is a prominent figure in the investment world. With a career spanning over four decades, Cohen has established a reputation for his savvy investment strategies and his firm's focus on long/short equity as its core strategy. Point72 operates on a multi-manager platform, emphasizing a fundamental bottom-up research process to inform its macro investments. The firm's top holdings include major players in the technology and healthcare sectors, such as Amazon.com Inc ( NASDAQ:AMZN ) and Boston Scientific Corp (
Show less
Read more
Impact Snapshot
Event Time:
ABEO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABEO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABEO alerts
High impacting Abeona Therapeutics Inc. news events
Weekly update
A roundup of the hottest topics
ABEO
News
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Abeona Therapeutics Inc. - ABEOPR Newswire
- Abeona Therapeutics Inc (NASDAQ: ABEO) had its price target lowered by analysts at Cantor Fitzgerald from $28.00 to $21.00. They now have an "overweight" rating on the stock.MarketBeat
- Abeona Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate ProgressGlobeNewswire
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Abeona Therapeutics Inc. - ABEOAccesswire
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Abeona Therapeutics Inc. - ABEOGlobeNewswire
ABEO
Earnings
- 5/15/24 - Miss
ABEO
Analyst Actions
- 5/16/24 - Cantor Fitzgerald
ABEO
Sec Filings
- 5/15/24 - Form S-8
- 5/15/24 - Form 10-Q
- 5/15/24 - Form 8-K
- ABEO's page on the SEC website